# Emergence of Human and Animal Melioidosis in Southern Africa, 2018–2021

**Authors:** Jennifer Rossouw, Hermanus D. W. Geyer, Monica Birkhead, Douglas Wilson, Jeremy Nel, Alan S. Karstaedt, Carel E. Haumann, Annelize Jonker, Jason W. Sahl, David M. Wagner, John A. Frean

PMC · DOI: 10.3390/tropicalmed11020060 · Tropical Medicine and Infectious Disease · 2026-02-19

## TL;DR

Melioidosis, a serious bacterial infection, has been identified for the first time in Southern Africa, highlighting the need for better surveillance and diagnostics.

## Contribution

First reported cases of melioidosis in humans and animals in Southern Africa, revealing the bacterium's long-term cryptic presence.

## Key findings

- Three human and two animal cases of melioidosis were identified in South Africa and Namibia between 2018 and 2021.
- Genomic analysis showed substantial diversity, indicating long-term persistence of Burkholderia pseudomallei in the region.
- Limited awareness and diagnostic capacity likely contribute to the disease's underreporting in Southern Africa.

## Abstract

Melioidosis is increasingly recognised in tropical and subtropical regions worldwide as a serious and potentially fatal bacterial infection affecting humans and animals, acquired from the environment. Until now, human cases of melioidosis had not been reported in Southern Africa. Over a four-year period, we identified three human and two animal cases of melioidosis in South Africa and Namibia. Burkholderia pseudomallei isolates were investigated by matrix-assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF MS) and whole-genome sequencing (WGS). Phylogenetic analysis demonstrated substantial diversity, suggesting long-term cryptic persistence of the bacterium in the Southern African region. Limited awareness of the disease and inadequate diagnostic capacity likely contribute to its apparent rarity in the region. These findings underscore the urgent need for increased surveillance, improved diagnostics, and greater awareness of melioidosis in Southern Africa to better understand its true epidemiological burden and prevent future cases.

## Linked entities

- **Diseases:** melioidosis (MONDO:0017775)
- **Species:** Burkholderia pseudomallei (taxon 28450)

## Full-text entities

- **Genes:** CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}
- **Diseases:** hilar lymphadenopathy (MESH:D018285), pneumonia (MESH:D011014), tuberculosis (MESH:D014376), vesicular dermatitis (MESH:D003872), neglected tropical disease (MESH:D058069), nausea (MESH:D009325), alcoholic liver disease (MESH:D008108), bacterial infection (MESH:D001424), pleural effusion (MESH:D010996), enteritis (MESH:D004751), type 2 diabetes (MESH:D003924), lymphadenopathy (MESH:D008206), necropurulent bronchopneumonia (MESH:D001996), Communicable Diseases (MESH:D003141), septicaemia (MESH:D018805), YLF (MESH:D015009), HIV-related immunodeficiency (MESH:D016263), necrotic (MESH:D009336), fever (MESH:D005334), respiratory distress (MESH:D012128), HIV infection (MESH:D015658), smoker (MESH:C000719328), death (MESH:D003643), hypertension (MESH:D006973), pain (MESH:D010146), Melioidosis (MESH:D008554), coccidiosis (MESH:D003048), pulmonary, gastrointestinal or neurological symptoms (MESH:D012817), abscess (MESH:D000038), injury to (MESH:D014947), dizziness (MESH:D004244), tropical diseases (MESH:D015493), swelling (MESH:D004487), chronic kidney disease (MESH:D051436), urinary tract infection (MESH:D014552), cough (MESH:D003371), malignancy (MESH:D009369), diabetes (MESH:D003920), acute or chronic infections (MESH:D054198), weakness (MESH:D018908), Klebsiella pneumoniae (MESH:D007710), lung lesion (MESH:D008171), infection (MESH:D007239), renal failure (MESH:D051437), pulmonary tuberculosis (MESH:D014397), loss of consciousness (MESH:D014474)
- **Chemicals:** polyhydroxybutyrate (MESH:C000720856), meropenem (MESH:D000077731), Resin (MESH:D012116), cefepime (MESH:D000077723), trimethoprim-sulfamethoxazole (MESH:D015662), ceftazidime (MESH:D002442), imipenem (MESH:D015378), creatinine (MESH:D003404), gentamicin (MESH:D005839), alcohol (MESH:D000438), tobramycin (MESH:D014031), azithromycin (MESH:D017963), API 20 (-), linezolid (MESH:D000069349), ciprofloxacin (MESH:D002939), amikacin (MESH:D000583), amoxicillin-clavulanic acid (MESH:D019980), piperacillin-tazobactam (MESH:D000077725)
- **Species:** Burkholderia thailandensis (species) [taxon 57975], Ovis aries (domestic sheep, species) [taxon 9940], Burkholderia cepacia (species) [taxon 292], Capra hircus (domestic goat, species) [taxon 9925], Human immunodeficiency virus 1 (no rank) [taxon 11676], Corynebacterium pseudotuberculosis (species) [taxon 1719], Burkholderia pseudomallei (species) [taxon 28450], Yersinia (genus) [taxon 444888], Homo sapiens (human, species) [taxon 9606], Burkholderia mallei (species) [taxon 13373]
- **Cell lines:** B1290-18 — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_7943)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12945296/full.md

## Figures

5 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12945296/full.md

## References

46 references — full list in the complete paper: https://tomesphere.com/paper/PMC12945296/full.md

---
Source: https://tomesphere.com/paper/PMC12945296